Markers of Outcome - a Cohort Study of LBP in Primary Health Care
Launched by KAROLINSKA INSTITUTET · Apr 10, 2017
Trial Information
Current as of June 03, 2025
Completed
Keywords
ClinConnect Summary
OVERALL AIM This project aims to through a praxis study (aim 1), a cohort study of markers of outcome (aim 2) tailor a patient cantered physiotherapy primary health care intervention (aim 3) in a randomized controlled trial.
1. Through a praxis study evaluate how physiotherapists in primary care use patient reported instruments and clinical tests when targeting treatment in LBP.
2. To conduct a nation-wide cohort study in primary care to identify markers at baseline to predict a poor or a successful outcome of LBP in the long term of 12 months following physiotherapeutic primary care. The ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Males and females above 16 years of age reporting pain of at least 2/10 on a Numeric Pain Rating Scale (NPRS) sufficient to cause them to modify their activities of daily living, and seeking care for LBP, ability to read and speak the Swedish language.
- Exclusion Criteria:
- • Participants are excluded if they have serious spinal pathology (i.e. fracture, metastatic disease), neurological disorders, severe spinal structural deformity, previous lower back surgery, pregnancy or other diagnoses that would require modification of the examination.
About Karolinska Institutet
Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stockholm, , Sweden
Patients applied
Trial Officials
Eva Rasmussen Barr, PhD
Principal Investigator
Karolinska Instiutet
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials